서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 10 of 10

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2004-07	Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy Lee, Jae Jin; Kim, Tae Min; Yu, Su Jong; Kim, Dong-Wan; Joh, Yo-han; Oh, Do-Youn; Kwon, Jung Hye; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.34 No.7, pp.400-404	DOI
2004-08	First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer Park, SH; Bang, SM; Cho, EK; Baek, JH; Oh, JH; Im, SA; Park, YS; Shin, DB; Lee, JH Oncology, Vol.66 No.5, pp.353-357	DOI
2005-08	A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer Cho, EK; Lee, WK; Im, SA; Lee, SN; Park, SH; Bang, SM; Park, DK; Park, YH; Shin, DB; Lee, JH Oncology, Vol.68 No.4-6, pp.333-340	DOI
2008-10	Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y. -J.; Goel, R.; Gollins, S.; Siu, L. L.; Laguerre, S.; Cunningham, D. Annals of Oncology, Vol.19 No.10, pp.1720-1726	DOI
2009-08	Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J. Annals of Oncology, Vol.20 No.8, pp.1402-1407	DOI
2011-12	Capecitabine in gastric cancer Bang, Yung-Jue Expert Review of Anticancer Therapy, Vol.11 No.12, pp.1791-1806	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2014-08	Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer Cha, Yongjun; Han, Sae-Won; Seol, Hyesil; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, In Ae; Han, Wonshik; Noh, Dong-Young; Kim, Tae-You Anticancer Research, Vol.34 No.8, pp.4275-4280
2015-12	Capecitabine for the treatment of gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue Expert Review of Gastroenterology and Hepatology, Vol.9 No.12, pp.1471-1481	DOI
2020-11	Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) Lee, Soohyeon; Im, Seock-Ah; Kim, Gun Min; Jung, Kyung Hae; Kang, Seok Yun; Park, In Hae; Kim, Jee Hyun; Lee, Kyoung Eun; Ahn, Hee Kyung; Lee, Moon Hee; Kim, Hee-Jun; Kim, Han Jo; Lee, Jong In; Koh, Su-Jin; Park, Yeon Hee Cancers, Vol.12 No.11, pp.3265-12	DOI

1